While much of Washington, D.C., was glued to debt ceiling negotiations between the White House and House Speaker Kevin McCarthy (R-CA), another high-stakes drama played out on Capitol Hill.
Bipartisan support began building for pharmacy benefit managers (PBM) to be more transparent and accountable for their influence on prescription drug prices and costs. This public policy goal should ultimately redound to the benefit of U.S. employers and millions of employees who rely on their healthcare plans.
